Quantification_NN
of_IN
vitamin_NN
D_NN
receptor_NN
mRNA_NN
by_IN
competitive_JJ
polymerase_NN
chain_NN
reaction_NN
in_IN
PBMC_NN
:_:
lack_NN
of_IN
correspondence_NN
with_IN
common_JJ
allelic_JJ
variants_NNS
._.

It_PRP
has_VBZ
been_VBN
recently_RB
claimed_VBN
that_IN
polymorphism_NN
for_IN
the_DT
vitamin_NN
D_NN
receptor_NN
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
influences_VBZ
several_JJ
aspects_NNS
of_IN
calcium_NN
and_CC
bone_NN
metabolism_NN
._.

To_TO
evaluate_VB
the_DT
physiologic_JJ
plausibility_NN
of_IN
these_DT
claims_NNS
,_,
we_PRP
compared_VBD
the_DT
abundance_NN
of_IN
the_DT
VDR_NN
mRNA_NN
in_IN
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
-LRB-_-LRB-
PBMCs_NNS
-RRB-_-RRB-
between_IN
different_JJ
VDR_NN
genotypes_NNS
using_VBG
a_DT
quantitative_JJ
reverse_JJ
transcribed_VBN
polymerase_NN
chain_NN
reaction-based_JJ
method_NN
._.

The_DT
method_NN
is_VBZ
based_VBN
on_IN
the_DT
coamplification_NN
of_IN
VDR_NN
cDNA_NN
and_CC
an_DT
internal_JJ
standard_NN
consisting_VBG
of_IN
known_JJ
concentrations_NNS
of_IN
a_DT
human_JJ
VDR_NN
CDNA_NN
mutated_VBN
at_IN
a_DT
BglII_NN
restriction_NN
site_NN
;_:
the_DT
interassay_JJ
coefficient_NN
of_IN
variation_NN
is_VBZ
11_CD
%_NN
._.

To_TO
validate_VB
the_DT
method_NN
,_,
we_PRP
made_VBD
use_NN
of_IN
earlier_JJR
receptor_NN
binding_NN
studies_NNS
indicating_VBG
that_IN
normal_JJ
human_JJ
monocytes_NNS
and_CC
activated_JJ
,_,
but_CC
not_RB
resting_JJ
,_,
lymphocytes_NNS
expressed_VBD
the_DT
VDR_NN
._.

The_DT
concentration_NN
of_IN
the_DT
VDR_NN
mRNA_NN
was_VBD
10_CD
-LRB-_-LRB-
-8_CD
-RRB-_-RRB-
to_TO
10_CD
-LRB-_-LRB-
-7_CD
-RRB-_-RRB-
g\/g_NN
of_IN
total_JJ
RNA_NN
in_IN
cell-sorted_JJ
monocytes_NNS
and_CC
in_IN
in_FW
vitro_FW
activated_VBN
lymphocytes_NNS
,_,
but_CC
only_RB
10_CD
-LRB-_-LRB-
-12_CD
-RRB-_-RRB-
g\/g_NN
of_IN
total_JJ
mRNA_NN
in_IN
resting_VBG
lymphocytes_NNS
,_,
establishing_VBG
that_IN
the_DT
VDR_NN
mRNA_NN
determined_VBN
by_IN
our_PRP$
method_NN
in_IN
PBMCs_NNS
is_VBZ
due_JJ
to_TO
constitutive_JJ
expression_NN
in_IN
monocytes_NNS
._.

Following_VBG
an_DT
initial_JJ
genotype_NN
screening_NN
of_IN
85_CD
normal_JJ
volunteers_NNS
by_IN
polymerase_NN
chain_NN
reaction_NN
or_CC
restriction_NN
fragment_NN
length_NN
polymorphism_NN
analysis_NN
,_,
14_CD
individuals_NNS
with_IN
the_DT
Bb_NN
genotype_NN
,_,
12_CD
with_IN
the_DT
bb_NN
genotype_NN
,_,
and_CC
12_CD
with_IN
the_DT
BB_NN
genotype_NN
were_VBD
selected_VBN
._.

The_DT
concentration_NN
of_IN
the_DT
VDR_NN
mRNA_NN
,_,
corrected_VBN
for_IN
the_DT
number_NN
of_IN
monocytes_NNS
,_,
was_VBD
similar_JJ
among_IN
the_DT
three_CD
genotype_NN
groups_NNS
,_,
as_IN
were_VBD
the_DT
other_JJ
variables_NNS
examined_VBN
:_:
serum_NN
calcitriol_NN
,_,
serum_NN
osteocalcin_NN
,_,
and_CC
vertebral_NN
and_CC
hip_NN
bone_NN
density_NN
._.

We_PRP
conclude_VBP
that_IN
VDR_NN
polymorphism_NN
does_VBZ
not_RB
affect_VB
the_DT
abundance_NN
of_IN
the_DT
VDR_NN
mRNA_NN
._.

